Axcella Health Inc expected to post a loss of 38 cents a share - Earnings Preview

Axcella Health

28/10/2022 19:33

* Axcella Health Inc  AXLA.OQ   AXLA.O  is expected to show
no
change in quarterly revenue when it reports  results on November
1. 
    * 
    * ​Refinitiv's mean analyst estimate for Axcella Health Inc
is for
a loss of 38 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 3.3%
in the last three months. ​
    * Wall Street's median 12-month price target for Axcella
Health
Inc is $8​, above​ its last closing price of $1.33. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.39       -0.38      -0.40     Missed  -5.3
 Mar. 31 2022  -0.36       -0.39      -0.46     Missed  -17.9
 Dec. 31 2021  -0.47       -0.45      -0.46     Missed  -2.9​
 Sep. 30 2021  -0.45       -0.46      -0.41     Beat    10.5
 ​​Jun.        -0.41       -0.43      -0.42     Beat    1.8
 30 2021                                                
 Mar. 31 2021  -0.42       -0.42      -0.40     Beat    4​
 Dec. 31 2020  -0.32       -0.36      -0.40     Missed  -10.8
 Sep. 30 2020  -0.39       -0.41      -0.34     Beat    16.6
 This summary was machine generated October 28 at 18:33 GMT.  All
figures in US dollars  unless otherwise stated